Maryam Asl-Soltani
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Hybrid regulatory T cells: camouflaged architects of tumor immunity.
Journal: Frontiers in immunology
Published: July 02, 2025
Soluble CTLA-4 - A confounding factor in CTLA-4 based checkpoint immunotherapy in cancer.
Journal: Immunology letters
Published: January 20, 2024
Landscape of unconventional γδ T cell subsets in cancer.
Journal: Molecular biology reports
Published: December 20, 2023
The combination of IDO and AHR blockers reduces the migration and clonogenicity of breast cancer cells.
Journal: Immunologic research
Published: September 05, 2023
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) as an undetermined tool in tumor cells.
Journal: Human cell
Published: January 17, 2023
Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment.
Journal: Molecular biology reports
Published: January 14, 2023
IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells.
Journal: Immunologic research
Published: November 16, 2022
The impact of leptin and its receptor polymorphisms on type 1 diabetes in a population of northwest Iran.
Journal: Annals of human biology
Published: October 11, 2022
C(3)1-TAg in C57BL/6 J background as a model to study mammary tumor development.
Journal: Histochemistry and cell biology
Published: May 09, 2021
Hematopoietic stem cell stretches and moves in its bone marrow niche.
Journal: Critical reviews in oncology/hematology
Published: July 14, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026